Your browser doesn't support javascript.
loading
Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors.
Tu, Yuanbiao; Wang, Caolin; Yang, Zunhua; Zhao, Bingbing; Lai, Luogen; Yang, Qi; Zheng, Pengwu; Zhu, Wufu.
Affiliation
  • Tu Y; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, PR China.
  • Wang C; Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, PR China.
  • Yang Z; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, PR China.
  • Zhao B; College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, PR China.
  • Lai L; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, PR China.
  • Yang Q; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, PR China.
  • Zheng P; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, PR China.
  • Zhu W; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, PR China.
Comput Struct Biotechnol J ; 16: 462-478, 2018.
Article in En | MEDLINE | ID: mdl-30455856

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Comput Struct Biotechnol J Year: 2018 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Comput Struct Biotechnol J Year: 2018 Document type: Article Country of publication: Netherlands